Sharon Longhurst
Director/Board Member at IDOGEN AB (PUBL)
Profile
Sharon Longhurst is currently an Independent Director at Idogen AB and Elicera Therapeutics AB.
Previously, she worked as the Head-Chemistry, Manufacturing & Control at Mendus AB and as the Vice President-Development at Gadeta BV from 2021 to 2023.
Dr. Longhurst holds a doctorate degree from the University of Warwick and an undergraduate degree from the University of Surrey.
Sharon Longhurst active positions
| Companies | Position | Start |
|---|---|---|
| IDOGEN AB (PUBL) | Director/Board Member | 11/05/2020 |
| ELICERA THERAPEUTICS AB | Director/Board Member | 31/12/2023 |
Former positions of Sharon Longhurst
| Companies | Position | End |
|---|---|---|
Gadeta BV
 Gadeta BV Medical SpecialtiesHealth Technology Gadeta BV discovers and develops novel cancer immunotherapies. It provides groundbreaking discoveries regarding the role of cell receptors in the broad of heamatological and solid tumor cells. The firm develops t-cells engineered to express a defined gamma delta, an anti- cancer product that eradicates tumors. The company was founded by Jurgen Kuball in 2015 and is headquartered in Utrecht, Netherlands. | Corporate Officer/Principal | 31/07/2023 |
| MENDUS AB | Corporate Officer/Principal | - |
Training of Sharon Longhurst
| University of Warwick | Doctorate Degree |
| University of Surrey | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 3 |
|---|---|
| IDOGEN AB (PUBL) | Health Technology |
| MENDUS AB | Health Technology |
| ELICERA THERAPEUTICS AB | Health Technology |
| Private companies | 1 |
|---|---|
Gadeta BV
Gadeta BV Medical SpecialtiesHealth Technology Gadeta BV discovers and develops novel cancer immunotherapies. It provides groundbreaking discoveries regarding the role of cell receptors in the broad of heamatological and solid tumor cells. The firm develops t-cells engineered to express a defined gamma delta, an anti- cancer product that eradicates tumors. The company was founded by Jurgen Kuball in 2015 and is headquartered in Utrecht, Netherlands. | Health Technology |
- Stock Market
- Insiders
- Sharon Longhurst
